Abstract:Abstract Background Rapid, reagent-free pathogen-agnostic diagnostics that can be performed at the point of need are vital for preparedness against future outbreaks. Yet, many current strategies (polymerase chain reaction, lateral flow immunoassays) are pathogen-specific and require reagents; whereas others such as sequencing-based methods; while agnostic, are not (as yet) conducive for use at the point of need. Herein, we present hyperspectral sensing as an opportunity to overcome these barriers, realizing truly agnostic reagent-free diagnostics. This approach can identify both pathogen and host signatures, without complex logistical considerations, in complex clinical samples. The spectral signature of biomolecules across multiple wavelength regimes provides rich biochemical information, which, coupled with machine learning, can facilitate expedited diagnosis of disease states, the feasibility of which is demonstrated here. Innovation First, we present ProSpectral(TM) V1, a novel, miniaturized (~8 lbs) hyperspectral platform with ultra-high (2-5 nm full-width, half-max, i.e., FWHM) spectral resolution that incorporates two mini-spectrometers (visual and near-infrared). This engineering innovation has enabled reagent-free biosensing for the first time. To enable expedient outcomes, we developed state-of-the-art machine learning algorithms for near real-time analysis of multi-wavelength spectral signatures in complex samples. Taken together, these innovations enable near-field ready, reagent-free, expedient agnostic diagnostics in complex clinical samples. Herein, we demonstrate the feasibility of this synergy of ProSpectral(TM) V1 with machine learning to accurately identify SARS-CoV-2 infection status in double-blinded saliva samples in real-time (3 seconds/measurement). The infection status of the samples was validated with the CDC-approved polymerase-chain reaction (PCR). We report accuracies comparable to first-in-class PCR tests. Further, we provide preliminary support that this signal is specific to SARS-CoV-2, and not associated with other respiratory conditions. Interpretation Preparedness against unanticipated pathogens and democratization of diagnostics requires moving away from technologies that demand specific reagents; and relying on intrinsic biochemical properties that can, theoretically, inform on all pathologies. Integration of hyperspectral sensors and in-line machine learning analytics, as reported here, shows the feasibility of such diagnostics. If realized to full potential, the ProSpectral(TM) V1 platform can enable agnostic diagnostics, thereby improving situational awareness and decision-making at the point of need; especially in resource-limited settings - enabling the distribution of newly developed tests for emerging pathogens with only a simple software update. Funding The U.S. Department of Energy, the Defense Threat Reduction Agency, Lawrence Berkeley National Laboratory, Los Alamos National Laboratory, and Pattern Computer Inc.

Opportunities for Enhanced Public Health Surveillance via Molecular Detection and Sequencing of Diverse Respiratory Viruses From Self-collected SARS-CoV-2 Antigen Test Swabs

Respiratory virus detection and sequencing from negative SARS-CoV-2 rapid antigen tests

881. Saliva-Based, Extraction-Free PCR Testing For The Detection Of Key Respiratory Pathogens

Metagenomic sequencing detects human respiratory and enteric viruses in air samples collected from congregate settings

Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discovery

SARS-CoV-2 genomic surveillance from community-distributed rapid antigen tests

Evaluation of Self-collected Saliva Samples Without Viral Transport Media for SARS-CoV-2 Testing via RT-PCR and Comparison of Amplicon Sequences Against Commonly Used Primers in Diagnostic Assays

Simultaneous detection and characterization of common respiratory pathogens in wastewater through genomic sequencing

Protocol for a winter sentinel surveillance program of notifiable respiratory viruses in Queensland

245 Detection of human respiratory pathogens in air and surface samples collected in several workplaces and public spaces

Multiplexed detection of SARS-CoV-2 and other respiratory infections in high throughput by SARSeq

Molecular detection of SARS-COV-2 in exhaled breath at the point-of-need

Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants

Detecting respiratory viral RNA using expanded genetic alphabets and self-avoiding DNA

Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights

Validation of an automated, end-to-end metagenomic sequencing assay for agnostic detection of respiratory viruses

Reagent-free Hyperspectral Diagnosis of SARS-CoV-2 Infection in saliva samples

School knowledge of infectious diseases in schools: conducting surveillance and on-demand, symptomatic respiratory viral testing in a large pre-kindergarten-12th grade school district

Assessment of a Program for SARS-CoV-2 Screening and Environmental Monitoring in an Urban Public School District